Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged Ashwath Damodaran

Ignore Warren Buffett’s Bearishness. We Must Buy Stocks Now Because Mega Bull Run Is Coming: Sanjiv Bhasin



Sanjiv-Bhasin

Warren Buffett and the other Pundits of Wall Street are/ were highly bearish about the CoronaVirus pandemic and failed to grab stocks at their lowest point. This led them to miss out on spectacular gains. Sanjiv Bhasin has advised that we should no longer listen to their advice because more gains are in the offing

Warren Buffett Under-performs S&P 500 (Over 10 Years) & Loses $25 Billion Leading To Directive That He Should No Longer Be Put On Pedestal & Worshipped Like Deity



Warren-Buffett

Investors in Warren Buffett’s Berkshire Hathaway are facing a harrowing time because the Fund has underperformed the S&P 500 over 10 years and also suffered a colossal loss of $25 Billion. Prof Ashwath Damodaran has now issued the directive that we should no longer put Warren Buffett on a pedestal and worship him

Prof Aswath Damodaran Explains Why Buying “Bad Companies” Makes A “Good Investment”



Prof Aswath Damodaran, an authority on valuation of businesses, has formulated the radical theory that buying “bad companies” at dirt cheap valuations is the best way to pocket multibagger gains. He has also provided a ready-made template which will help us to home in on the best stocks to buy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 493 other subscribers

RSS Stocks Talk Forum

  • Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap)
    Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap) for Nov '24. The Basket has delivered return of 329% since inception (May’20) vs 162% return delivered by NIFTY Index over the same period due to thematic approach to Top Picks selection Download report
  • Shalby is a multi-specialty hospital chain with expertise in joint replacement
    Shalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
  • DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
    DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!